💨 Abstract

The Central Drugs Standard Control Organisation (CDSCO) has issued an urgent directive to stop the manufacturing and marketing of unapproved Fixed Dose Combination (FDC) drugs, posing a risk to public health. The directive orders the stopping of 35 FDC drugs and any other unapproved medicines. This action is due to the unapproved FDC compromising patient safety and lacking uniform enforcement of regulations.

Courtesy: theprint.in